Creating new perspectives in healthcare
We are driven by the purpose of improving lives through pharmaceutical innovation. Knowing that our knowledge and expertise can concretely improve people’s health and well-being, we strive every day to improve healthcare by researching and developing innovative solutions for disease prevention, management, and cure. Our daily work is inspired by the firm belief that everyone deserves access to healthcare that empowers them to live their lives to the fullest.
Italfarmaco Group
[add local affiliate name] is part of Italfarmaco Group, a private multinational group founded in 1938 and based in Milan, Italy. We produce high-quality medicinal specialties adhering to the highest quality standards. We are committed to improving patients’ lives and overall well-being through pioneering research and development, high-quality production, and global marketing of branded prescription and non-prescription products.
Mission
Italfarmaco Group is a leading organization that specializes in the development, manufacture, and marketing of prescription and non-prescription products. Our primary objective is to increase our investment in research and development activities, with a particular focus on developing high-quality, effective solutions for patients and healthcare providers worldwide. We are also committed to developing innovative treatments for specialty and rare diseases. Our organization is dedicated to excellence and we work to achieve sustainable growth and have a positive impact on society and the environment.
Our Values
A glance to our value
FCST GROSS
SALES 2024
PROPRIETARY
PRODUCTS
INVESTMENT IN MANUFACTURING
(2020-2024)
PRODUCT INDUSTRIAL
UNITS PER YEAR
Our production plants
We oversee the entire process of creating drugs, from start to finish, to ensure their quality as medicines. We have six advanced production facilities; in each, we manufacture different products: injectable and solid oral products in Milan; liquid oral products in Madrid and Santiago de Chile; semi-solid products in Barcelona; API products in Frosinone (Italy) and Salvador de Bahia manufacture. We also have Chemi Spa, an Italian pharmaceutical chemical company that produces complex molecules, including the synthesis of the active ingredient (API) and the pharmaceutical form of injectable drugs.
We continuously invest in technology to maintain modern, flexible facilities, a high production capacity, quality, safety, and environmental sustainability, as modern disease solutions require a contemporary approach.
